Bayer is eager to brush up its drug development pipeline after its agriculture business was hit by 9.25 billion euros ($10.8 billion) in impairment …
Read Complete New : Bayer strikes deal with Atara Biotherapeutics to jointly work on CAR-T cell anti-tumour treatments